118th Congress · SENATE BILLBILL

S. 3621Medical Device Nonvisual Accessibility Act of 2024

A bill to amend the Federal Food, Drug, and Cosmetic Act to establish nonvisual accessibility standards for certain devices with digital interfaces, and for other purposes.

Health
Introduced Jan 18, 2024
Last action Jan 18, 2024
Pipeline · Bill → Law
Step 1
Introduced
Jan 18, 2024
Step 2
Referred
Jan 18, 2024
HELP
Step 3
Committee
Step 4
Senate
Step 5
House floor
Step 6
Resolve Changes
Step 7
Signed
SummaryCRS Summary

This bill requires certain medical devices with a digital interface to meet nonvisual accessibility standards established by the Food and Drug Administration (FDA). Specifically, the FDA must establish regulations to require a Class II or Class III medical device with a digital interface to provide a blind or low-vision user access to the same services and information, and generally the same ease of use, as provided to a user who is not low-vision or blind. (The FDA classifies medical devices in three classes. Class I devices are low-risk, Class II devices are moderate-risk, and Class III devices are high-risk.) A Class II or Class III medical device that does not meet the nonvisual access...

Provisions · 3 sectionsIntroduced in Senate
Timeline · 2 actions
Jan 18, 2024
Introduced in Senate
Jan 18, 2024
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.